Do You Have Cancer Cells?
MyGenia® Circulating DNA Early Cancer Screening
MyGenia® Circulating DNA Early Cancer Screening can detect if there are any active cancer cells in the patient’s body that can cause abnormality in the DNA. The traditional methods of circulating tumor DNA (ctDNA) screening involves blood tests and Radioimmunoassay (RIA) to track the location of the cancer cells. MyGenia® Circulating DNA Early Cancer Screening, however, has simplified the process with the advancement of technology. When cancer cells die from necrosis during metabolism, our DNA will be released into the blood plasmas (ctDNA). Blood will be drawn from the patient, and the DNA arrangement will be studied and tested for the signs of cancer cells. Consequently, the subject of the test can plan birth-giving, prevent diseases, or enquire about their physical well-being accordingly, in hopes of a better maintenance of the future of their personal health.
What is Cancer?
Our body’s functions are programed by our DNA codes. However, when these codes have “bugs”, our body may not function properly. These “bugs” in our DNA are called “genetic mutations”. There are various causes which may lead to genetic mutations, such as lifestyle, diet, environmental pollution, age and even by inheritance. Our DNA itself may also mutate during normal replication. Many mutations may not affect the normal functioning of our body. However, if the mutations lead to diseases, then these mutations are called pathogenic mutations. There are two basic types of genetic mutations: Acquired mutations are the most common cause of cancer. These occur from damages to genes during a person’s life. Factors that cause these mutations include tobacco smoking, ultraviolet (UV) radiation, viruses, and aging. Germline mutations, on the other hand, are passed directly from a parent to a child. In these situations, the mutations can be found in every cell of a person’s body, including the reproductive sperm cells in male and egg cells in female.
Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells to replace old cells, a process called “metabolism” to maintain its balance. Sometimes this process goes wrong due to genetic mutations. New cells grow in an uncontrolled manner, and old cells are becoming “immortal”. These “extra cells” will form a mass called tumor. Tumors can be benign or malignant. Malignant tumors will ultimately turn to be cancers.
MyGenia® Technology is Fast
What makes MyGenia better than traditional screening methods is its advantage in speed. If cancer cells can be detected as earlier as possible, the patient will have more time to seek immediate treatment.
Details of MyGenia® Test
Name of the test: MyGenia® Circulating DNA Early Cancer Screening
Test code: OCT
Duration: 6 Working Days
Sample needed: 10ml blood of the subject
Storage temperature: 4°C
Technology used: Next-Generation Sequencing (NGS)
The test only requires 10ml of the subject’s blood without doing harm to his/her body, and it can cover 27 types of men and 30 types of women’s commonly-found tumors and cancer. MyGenia® is also the pioneer in Hong Kong that owns an NGS machine and a private laboratory to carry out the test. This technology (NGS) can reach 99.9% of accuracy.
Who is the Test for?
- Healthy individual of any age
- Individual with all kinds of chronic diseases or with a weak immune system
- Individual who is constantly exposed to highly radio-active or polluted environments
- Concerned individual
- Individual with an unhealthy lifestyle
- Smoking cigarettes, drinking alcohol or having an unhealthy diet
- Overweight, insufficient exercise
- Individuals whose family member(s) has/have genetic diseases
- More than one family members who got the same type of cancer
- More than one family members who have rare tumors
For more details, please visit: http://www.pangenia.com/zh/test/detail/mygenia-cancer-health-risk-assessment-test